Literature DB >> 21125661

Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions.

Janelle Drouin-Ouellet1, Anna-Liisa Brownell, Martine Saint-Pierre, Caroline Fasano, Vincent Emond, Louis-Eric Trudeau, Daniel Lévesque, Francesca Cicchetti.   

Abstract

It has been hypothesized that neuroinflammation triggered during brain development can alter brain functions later in life. We investigated the contribution of inflammation to the alteration of normal brain circuitries in the context of neuroexcitotoxicity following neonatal ventral hippocampal lesions in rats with ibotenic acid, an NMDA glutamate receptor agonist. Excitotoxic ibotenic acid lesions led to a significant and persistent astrogliosis and microglial activation, associated with the production of inflammatory mediators. This response was accompanied by a significant increase in metabotropic glutamate receptor type 5 (mGluR5) expression within two distinct neuroinflammatory cell types; astrocytes and microglia. The participation of inflammation to the neurotoxin-induced lesion was further supported by the prevention of hippocampal neuronal loss, glial mGluR5 expression and some of the behavioral perturbations associated to the excitotoxic lesion by concurrent anti-inflammatory treatment with minocycline. These results indicate that neuroinflammation significantly contributes to long-lasting excitotoxic effects of the neurotoxin and to some behavioral phenotypes associated with this model. Thus, the control of the inflammatory response may prevent the deleterious effects of excitotoxic processes that are triggered during brain development, limiting the risk to develop some of the behavioral manifestations related to these processes in adulthood.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21125661      PMCID: PMC3983848          DOI: 10.1002/glia.21086

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  46 in total

1.  Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia.

Authors:  José Borrell; José Miguel Vela; Angel Arévalo-Martin; Eduardo Molina-Holgado; Carmen Guaza
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

Review 2.  Peripheral metabotropic glutamate receptors as drug targets for pain relief.

Authors:  Volker Neugebauer; Susan M Carlton
Journal:  Expert Opin Ther Targets       Date:  2002-06       Impact factor: 6.902

3.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Possible antipsychotic effects of minocycline in patients with schizophrenia.

Authors:  Tsuyoshi Miyaoka; Rei Yasukawa; Hideaki Yasuda; Maiko Hayashida; Takuji Inagaki; Jun Horiguchi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-10-05       Impact factor: 5.067

5.  Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat.

Authors:  Barbara K Lipska; Nader D Halim; Pavan N Segal; Daniel R Weinberger
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 6.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

7.  Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.

Authors:  Ji-Quan Wang; Werner Tueckmantel; Aijun Zhu; Daniela Pellegrino; Anna-Liisa Brownell
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

Review 8.  Neurotoxicity of glucocorticoids in the primate brain.

Authors:  H Uno; S Eisele; A Sakai; S Shelton; E Baker; O DeJesus; J Holden
Journal:  Horm Behav       Date:  1994-12       Impact factor: 3.587

9.  Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase.

Authors:  David J Loane; Bogdan A Stoica; Ahdeah Pajoohesh-Ganji; Kimberly R Byrnes; Alan I Faden
Journal:  J Biol Chem       Date:  2009-04-13       Impact factor: 5.157

10.  Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.

Authors:  Tsu F Yeh; Yuh J Lin; Hung C Lin; Chao C Huang; Wu S Hsieh; Chyi H Lin; Cheng H Tsai
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

View more
  28 in total

1.  Metabotropic glutamate receptor-mediated signaling in neuroglia.

Authors:  David J Loane; Bogdan A Stoica; Alan I Faden
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-11

2.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

3.  Activation of mGluR5 Attenuates Microglial Activation and Neuronal Apoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.

Authors:  Zong-Yong Zhang; Bao-Liang Sun; Jun-Ke Liu; Ming-Feng Yang; Da-Wei Li; Jie Fang; Shuai Zhang; Qi-Lin Yuan; Si-Luo Huang
Journal:  Neurochem Res       Date:  2015-04-07       Impact factor: 3.996

4.  Selective lesion of the hippocampus increases the differentiation of immature neurons in the monkey amygdala.

Authors:  Loïc J Chareyron; David G Amaral; Pierre Lavenex
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

5.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

Review 6.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

7.  Co-operative binding assay for the characterization of mGlu4 allosteric modulators.

Authors:  Pekka Poutiainen; Kun-Eek Kil; Zhaoda Zhang; Darshini Kuruppu; Bakhos Tannous; Anna-Liisa Brownell
Journal:  Neuropharmacology       Date:  2015-05-27       Impact factor: 5.250

8.  Development of [(123)I]IPEB and [(123)I]IMPEB as SPECT Radioligands for Metabotropic Glutamate Receptor Subtype 5.

Authors:  Kun-Eek Kil; Aijun Zhu; Zhaoda Zhang; Ji-Kyung Choi; Sreekanth Kura; Chunyu Gong; Anna-Liisa Brownell
Journal:  ACS Med Chem Lett       Date:  2014-04-06       Impact factor: 4.345

9.  Attenuation of Acute Intracerebral Hemorrhage-Induced Microglial Activation and Neuronal Death Mediated by the Blockade of Metabotropic Glutamate Receptor 5 In Vivo.

Authors:  Md Saidur Rahman; Jianbo Yang; Yan Luan; Zhengguo Qiu; Jianshui Zhang; Haixia Lu; Xinlin Chen; Yong Liu
Journal:  Neurochem Res       Date:  2020-03-05       Impact factor: 3.996

10.  Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients.

Authors:  Adrienne Müller Herde; Roger Schibli; Markus Weber; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.